Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:174720.
doi: 10.1155/2015/174720. Epub 2015 Apr 20.

Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis

Affiliations
Review

Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis

Masoud Etemadifar et al. Mult Scler Int. 2015.

Abstract

Background. Neuromyelitis optica (Devic's disease) is a severe autoimmune inflammatory disorder of the central nervous system. Epidemiological aspects of NMO have not been systemically reviewed. In this study we systematically reviewed and assessed the quality of studies reporting the incidence and/or prevalence of NMO across the world. Methods. A comprehensive literature search using MEDLINE, EMBASE, and Web of Science for the terms "Neuromyelitis optica," "devic disease," "incidence," "prevalence," and "epidemiology" was conducted on January 31, 2015. Study quality was assessed using an assessment tool based on recognized guidelines and designed specifically for this study. Results. A total of 216 studies were initially identified, with only 9 meeting the inclusion criteria. High level of heterogeneity amongst studies precluded a firm conclusion. Incidence data were found in four studies and ranged from 0.053 per 100,000 per year in Cuba to 0.4 in Southern Denmark. Prevalence was reported in all studies and ranged from 0.51 per 100,000 in Cuba to 4.4 in Southern Denmark. Conclusion. This review reveals the gaps that still exist in the epidemiological knowledge of NMO in the world. Published studies have different qualities and methodology precluding a robust conclusion. Future researches focusing on epidemiological features of NMO in different nations and different ethnic groups are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of selection of NMO incidence and prevalence studies within January 1, 1985–January 31, 2015.
Figure 2
Figure 2
Prevalence of Neuromyelitis optica globally. (Data gathered from query data of Multiple Sclerosis International Federation (MSIF).)

Similar articles

Cited by

References

    1. Wingerchuk D. M., Lennon V. A., Pittock S. J., Lucchinetti C. F., Weinshenker B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485–1489. doi: 10.1212/01.wnl.0000216139.44259.74. - DOI - PubMed
    1. Matà S., Lolli F. Neuromyelitis optica: an update. Journal of the Neurological Sciences. 2011;303(1-2):13–21. doi: 10.1016/j.jns.2011.01.002. - DOI - PubMed
    1. Lennon P. V. A., Wingerchuk D. M., Kryzer T. J., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. The Lancet. 2004;364(9451):2106–2112. doi: 10.1016/s0140-6736(04)17551-x. - DOI - PubMed
    1. Fazio R., Radaelli M., Furlan R. Neuromyelitis optica: concepts in evolution. Journal of Neuroimmunology. 2011;231(1-2):100–104. doi: 10.1016/j.jneuroim.2010.10.012. - DOI - PubMed
    1. Wingerchuk D. M., Hogancamp W. F., O'Brien P. C., Weinshenker B. G. The clinical course of neuromyelitis optica (Devic's syndrome) Neurology. 1999;53(5):1107–1114. doi: 10.1212/WNL.53.5.1107. - DOI - PubMed

LinkOut - more resources